The difference in prevalence rates between the two populations was statistically significant for all age groups, but of borderline significance in the age groups of 40–49-year olds and 70–79-year olds.
← all excerpts
Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.
1
—
—